Extracorporeal shockwave lithotripsy (ESWL): ESWL, two treatments with an interval of two days or three weeks.
Study summary
Extracorporeal shockwave lithotripsy (ESWL) is one way to treat renal stones. In this clinical trial our goal is to evaluate if two ESWL the same week is equal good and safe to two ESWL 3 weeks regarding renal stones 8-15 mm.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: All patients with a renal stone 8-15 mm who are planned for intervention -
Exclusion Criteria: Those who decline to participate, those who are put under guardianship or is less than 18 years old.
\-
Primary outcome measure(s)
Time to stone free status — From enrollment until closure Number of days from the day the treatment starts until the end of follow up.
Complications — From enrollment until closure Are there any differences in complications
Number of participants considered stone free at follow up — From enrollment until closure. Number of participants who are stone free at the follow up after two ESWL. Stone status will be assessed with computer tomography.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
